-
Bayer and Novartis have been unsuccessful in their case against a policy adopted by CCGs in the North of England
-
Research by Harvard University scientists could expand the range of optical and biopharmaceutical materials that can be created
-
While emphasising that a departure from the EU without agreement is ‘unlikely,’ the Government has released guidance on potential healthcare implications
-
A robot that is only 120 nanometres in size has been created by US scientists
-
The potential for adverse antibiotic reactions among children has been highlighted by researchers
-
The US Food and Drug Administration has approved Oxervate for the treatment of a rare disease of the cornea
-
Scientists have identified a biological clue that could help clinicians identify which diabetic macular oedema patients will respond best to treatment
-
A new report has found that the AMD market across the US, France, Germany, Italy, Spain, Japan and the UK is expected to grow at a rate of 8.9%
-
Spanish scientists are developing a thin, transparent insert that is placed inside the eyelid to fight bacterial infection
-
Consultant ophthalmologist, Omar Mahroo, reminded practitioners about the potential eye health risks of hydroxychloroquine at Optometry Tomorrow